Results 191 to 200 of about 220,169 (313)

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Personalizing product sets to individual health priorities increases the healthfulness of hypothetical food choices in US adults. [PDF]

Sci Rep
Gustafson CR, Gitungwa H, Boron JB, Rose DJ.   +3 more
europepmc   +1 more source

Cardiovascular Health—A Workplace Priority [PDF]

AAOHN Journal, 2002
openaire   +2 more sources

Situación actual, prioridades de actuación y necesidades de investigación en contaminación atmosférica y salud en España: conclusiones del Taller AIRNET de Barcelona Current situation, priorities for intervention and research needs in air pollution and health in Spain: conclusions of the AIRNET Network Day in Barcelona

, 2007
Ferrán Ballester, Xavier Querol, Sylvia Médina, J. M. Baldasano, Jordi Sunyer   +4 more
openalex   +1 more source

Occupational health research priorities in Malaysia: a Delphi study [PDF]

, 2001
S Sadhra, Jeremy Beach, T-C Aw, K Sheikh-Ahmed   +3 more
openalex   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Leveraging State-Supported Continuing Education for Health Care Professionals to Address Public Health Priorities: A 5-Year Retrospective Case Study on the District of Columbia Program. [PDF]

Public Health Rep
Downing G, Mayewski Z, Tramontozzi LM, Plotke M, Ortique J.   +4 more
europepmc   +1 more source

Priority Setting for Health: A Critique of Alternative Models: Report to the Population Health Division Department of Health and Aged Care

, 2017
Leonie Segal, Ying Chen
openalex   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source

The National Center for Complementary and Integrative Health: Priorities for Cannabis and Cannabinoid Research. [PDF]

J Pharmacol Exp Ther
Shurtleff D, Arensdorf A, Still PC, Gust SW, Chideya S, Hopp DC, Belfer I.   +6 more
europepmc   +1 more source